info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0079019-01
Couldn't load pickup availability
Mivebresib (ABBV-075) is a potent and orally active bromodomain and extraterminal domain (BET) bromodomain inhibitor. Mivebresib binds to BRD4 with a Ki of 1.5 nM[1].
[1445993-26-9]
C22H19F2N3O4S
459.47
CCS(=O)(NC1=CC=C(OC2=CC=C(F)C=C2F)C(C3=CN(C)C(C4=C3C=CN4)=O)=C1)=O
Apoptosis; Epigenetic Reader Domain
99.69
DMSO : 100 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)
-20°C, 3 years; 4°C, 2 years (Powder)
Room Temperature
H315, H319, H335
Loading...
Total items
Product subtotal
Mivebresib is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.